Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Butyrospermum parkii, commonly known as the shea tree, is the source of shea butter, a fat extracted from the nuts of the tree. [1, 5, 8] It is widely used in cosmetic and skincare products as an emollient and moisturizer. [1, 2] The butter is rich in fatty acids, such as stearic and oleic acids, which help to condition the skin and support its barrier function. [4, 7] It also contains a significant unsaponifiable fraction rich in antioxidants like vitamin E and phenols, and anti-inflammatory compounds like triterpene esters. [4, 7, 9] These components contribute to its soothing, protective, and regenerative properties. [1, 9] It is generally considered safe for topical use, even on sensitive skin, and is used to manage conditions like dry skin, eczema, and dermatitis. [3, 10, 11, 12] The U.S. FDA recognizes it as Generally Recognized as Safe (GRAS) for use in food. [3, 8]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Butyrospermum parkii.